Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

Abstract
No abstract available
Funding Information
  • Eisai

This publication has 21 references indexed in Scilit: